Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.
ISCHEMIC HEART DISEASE IS THE LEADING CAUSE of morbidity and mortality in the US and other developed nations (5) . In most cases, congestive heart failure is treated pharmacologically to increase the heart contractility, reduce blood pressure, or reduce fluid volume (13) . Current therapies aim largely to attenuate the pathological remodeling that occurs after injury and to reduce risk factors for cardiovascular disease. Although this approach can be effective in some cases, it does not represent a cure but rather a palliative measure. Potentially more severe and acute sequelae of MI include aneurysm of the heart wall with potential for rupture and conduction abnormalities, both of which result in sudden cardiac death (19) . Heart transplantation is currently the leading therapy for patients with heart failure, but it is limited by the amount of the donated organs (7) . Tissue engineering strategies continue to be explored as an approach to repair and restore functionality to damaged heart muscle. Because cardiac muscle is a highly metabolic tissue and is sensitive to hypoxia, there is very limited potential to regenerate following acute ischemic events. Consequently, ischemia leads to loss of cardiac tissue, formation of dysfunctional permanent scar tissue, and, ultimately, heart failure (24) . One potentially attractive tissue-engineering approach is based on the use of cardiac cell sheet grafts to replace or repopulate dead or damaged tissue with viable functioning cell types (12) . This approach focuses on efficient cell penetration from a cell patch into ischemic myocardium. Ideally, this would result in transformation of these cells into functional myocytes with coordinated angiogenesis.
Stroma-derived factor-1␣ (SDF-1␣), a major chemokine attracting peripheral progenitor/stem cells to the heart, appears to be important to the reverse remodeling tissue process. SDF-1␣ binds to CXCR4 in its active form (30) and is cleaved and inactivated by CD26/dipeptidyl peptidase IV (DPP-IV) (2, 30) . It has been demonstrated previously that SDF-1␣ expression and cellular release of this cytokine occurred for several days after acute MI, whereas SDF-1␣ release from the ischemic heart tissue was not sustained for more than ϳ7 days (32) . In addition, we reported previously that overexpression of CXCR4 in mesenchymal stem cells (MSC) significantly increases the release of angiogenic factors during tissue hypoxia (6) . Consequently, we postulated that approaches to sustain SDF-1␣ levels by inhibiting its enzymatic degradation using diprotin A pretreatment might enhance cell migration, engraftment, and tissue reverse modeling, which in aggregate could yield positive functional effects in MI. Accordingly, to putatively attract and increase the integration of CXCR4 ϩ progenitor cells in a region of myocardial ischemia in response to a sustained SDF-1␣ gradient, we genetically engineered male rat MSC using ex vivo adenoviral transduction to overexpress CXCR4 to examine the efficacy of this approach. We hypothesized that the overexpression of CXCR4 in progenitor cells combined with systemic pretreatment with diprotin A would enhance MSC recruitment and penetration into ischemic myocardium, thereby leading to enhanced reverse myocardial remodeling of infarcted and peri-infarcted regions with accompanying improvements in both local vascularity and left ventricle (LV) contractile function.
METHODS
Experiments using animal subjects or animal-derived materials were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Publication No. 85-23, revised 1996) and University of Cincinnati Institutional Animal Care and Use Guidelines. Our experiments were approved by the University of Cincinnati Institutional Animal Care and Use Committee.
MSC isolation, culture, and labeling. MSC were obtained from male Sprague-Dawley (SD) 8-wk-old rats as described (32) . The confluent MSC in the seed cultures were removed from the flask by 0.25% trypsin (Sigma, St. Louis, MO). Passage 2-4 MSC were used in the study. The AdEasy TM Vector System (Qbiogene) was used for regenerating recombinant adenovirus according to the manufacturer's instructions. Recombinant adenovirus vector was generated and prepared as described previously (32) . In brief, the primers for quantitative PCR containing BglII (5=) and HindIII (3=) linkers were synthesized as follows: CXCR4 forward primer 5=-CAGA AGA TCT GTT GCC ATG GAA CCG ATC-3=, CXCR4 reverse primer 5=-CAGA AAG CTT GGG TTA GCT GGA GTG-3=; siRNA targeting CXCR4 gene forward primer 5=-CAC CGG ATC AGC ATC GAT TCC TTC ACG AAT GAA GGA ATC GAT GCT GAT CC-3=, siRNA targeting CXCR4 gene reverse primer 5=-AAA AGG ATC AGC ATC GAT TCC TTC ATT CGT GAA GGA ATC GAT GCT GAT CC-3=. For transfections, MSC were seeded on six-well plates at 5 ϫ 10 4 cells/ml 24 h before treatment, resulting in ϳ60% confluence at the time of transfection. MSC were transduced overnight using dilutions of concentrated virus equivalent to 1 ϫ 10 7 infectious units in non-FBS medium, and MSC were assigned to the experimental groups. Since recombinant adenovirus expresses both enhanced green fluorescent protein (EGFP) and CXCR4 (32) , transfection efficiency of MSC with the viral system was evaluated by flow cytometry.
Preparation of monolayered cell sheet. Above-treated MSC (5 ϫ 10 4 ) with 3 ml of culture medium were seeded onto 3.5-cm temperature-responsive dishes purchased from CellSeed and cultured cells with 10% FBS-DMEM culture medium at 37°C. After 7 days of culture, confluently cultured MSC on the temperature-responsive dishes were incubated at 20°C. Within 10 -20 min, MSC detached spontaneously and floated up into the medium as monolayered cell sheets. Immediately after detachment, MSC were gently aspirated using a 1,000-l pipette tip and transferred onto the infarcted area of the myocardium as described (14) . 1, 7, 14, 21 , or 28 after cell sheet implantation, transthoracic echocardiography was performed. Animals were euthanized for the left ventricular tissue sampling to measure DPP-IV activity and SDF-1␣ level 7 days after LAD in a subset of study. For apoptosis, additional hearts (n ϭ 4 for each group) were isolated 4 days after LAD ligation for terminal deoxynucleotidyl-mediated dUTP nick-end labeling (TUNEL) assays. The remaining study animals were euthanized 28 days after cell sheet implantation for immunohistochemical staining of heart tissues to characterize angiogenesis outside of epicardium (cell sheet graft), the infarcted or peri-infarcted region.
Surgical procedures for MI. A MI model was developed in SD female rats, as described previously (27) . Briefly, isoflurane anesthesia was induced by spontaneous inhalation and maintained under general anesthesia with 1-2% isoflurane. The inhalation gas was a mixture of air and oxygen (total oxygen 40%) and 2.4% isoflurane. The animals were mechanically ventilated using a rodent ventilator (model 683; Harvard Apparatus, South Natick, MA) connected to a tracheal tube. The heart was exposed by left-side limited thoracotomy, and LAD was ligated with a 6-0 polyester suture 1 mm from tip of the normally positioned left auricle. Before the thoracic cavity was closed, positive end-expiratory pressure was applied to fully inflate the lungs, and then muscle layers and skin were closed separately. Left thoracic cavity was finally reopened, and a monolayered cell sheet was placed onto the epicardial surface overlying the infarcted area on day 7 after LAD ligation.
Measurement of DPP-IV activity. After 7 days of pretreatment with vehicle or diprotin A, hearts were isolated, and tissues from LV in various treatment groups on day 7 after LAD ligation or on day 28 after cell sheet implantation were then lysed by homogenize and ultrasonic. After centrifuge, the supernatants were stored at Ϫ80°C for DPP-IV activity assay. Enzyme activity of DPP-IV was measured according to the assay of DPP-IV (20) . In brief, 0.1 ml of incubation buffer was mixed with 20 l of heart extract and kept at 37°C. Ten microliters of substrate solution (Gly-Pro-4-Me-2-NA, 20 mM, in DMSO) was added into the mixture to start the reaction and incubated at 37°C for 20 min. The reaction was stopped by adding 1 ml of citrate solution (100 mM, pH 4.0) and then vortex-mixed for 30 s. Within 1 h after termination of the reaction, the fluorescence at 340 and 425 nm (excitation and emission wavelengths, respectively) was measured. One unit (U) of DPP-IV activity is defined as the enzyme activity that produces 1 m of 4-methoxy-2-naphthylamine in 1 min under the conditions described. DPP-IV activity in hearts was calculated from the equation activity, U/l ϭ (F·V t · 1,000 Ϫ Cst)/(T ·Vs ·Fst) (20) , ) were seeded on a temperature-responsive dish, and these cells expanded to confluence on the square slide at 7 days. B: the monolayered MSC CXCR4 started to detach from the bottom of the dish when it was incubated at 20°C for 10 min. C: reconstructed confocal images (xz planes) were shown before cell detached. D: after detachment, the thickness of the cell sheet was ϳ2.5-fold greater than the thickness before detachment. E: immuonostaining revealed that connexine-43, a gap junction protein (white arrow), existed in the membrane of cells in the cell sheet of CXCR4 group, mediating cell-to-cell communication. Scale bars in C and D are 25 m.
where F is the fluorescence of the supernatants of heart extract minus the fluorescence of the blank, V t indicates the total assay volume (1.13 ml), 1,000 is the factor for conversion from U/ml to U/l, Cst is the standard concentration (mol/l), T is the incubation time (20 min), Vs is the sample volume (20 l), and Fst is the fluorescence of the standard minus fluorescence of the solvent.
Measurement of SDF-1␣ level.
Samples from the LV on day 7 after LAD ligation were purified from recombinant SDF-1␣ that was incubated with various groups of heart extract, as indicated in a total volume of 40 l of PBS. After incubation, the cleavage products were incubated for 3 h with 5 l of an anti-SDF-1 antibody (Torrey Pines Biolaboratories) and 10 l of a 1:1 slurry of protein G-Sepharose (Sigma) in PBS, as described previously (8, 30) . After incubation, beads were collected by centrifugation and washed three times with 100 l of immunoprecipitation buffer (140 mM NaCl, 0.1% N-octyle glycopyranoside, 10 mM Tris · HCl, pH 8.0, 5 mM EDTA) and two times with 100 l of H 2O. Finally, all of the buffer solution was aspirated from the beads, and the semidried beads were incubated with 10 l of a 50% acetonitrile and 0.6% trifluoroacetic acid solution for 5 min to elute the bound peptide. An aliquot (4 l) of the eluted sample was mixed with a saturated CHCN solution, spotted completely to a stainless-steel target plate, and analyzed in a MALDI-TOF mass spectrometer (3) .
Immunohistochemical analysis. The immunohistochemical studies were performed on heart tissues on day 28 after the MSC grafts were applied to the area of LAD distribution. Heart tissue sections were harvested, fixed in 10% formalin, and sectioned at 5-m thickness. Von Willebrand factor (vWF) antibody (Santa Cruz Biotechnology) was used to assess angiogenesis and capillary density and, connexin-43 antibody (Santa Cruz Biotechnology) was used to evaluate cell integration, whereas 4,6-diamino-2-phenylindole (DAPI; Sigma) was used to identify nuclei. Fluorescent imaging was performed with an Olympus BX41 microscope (Olympus America, Melville, NY) equipped with epiflourescence attachment, and images were recorded using a digital camera with MagnaFire 2.1 software. FISH analysis of heart tissue samples was carried out using STAR*FISH Rat 12/Y Paints Protocol (CA-1631), as described previously (32) . Confocal images were obtained with a Leitz DMRBE fluorescence microscope equipped with TCS 4D confocal scanning attachments (Leica).
TUNEL assay. For apoptosis, additional hearts (n ϭ 4 for each group) were isolated 4 days after LAD ligation for deoxynucleotide transferase-mediated dUTP nick assays. The TUNEL assay was performed on 5-m-thick deparaffinized histological sections, using MEBSTAIN Apoptosis Kit II (Medical and Biological Laboratories). The sections were made at the mid-LV of the heart and were processed with fluorescent TUNEL using the previously described method (25) . The total number of TUNEL-positive myocyte nuclei in the noninfarcted region was counted and normalized to the total number of nuclei in the sections. Apoptotic myocytes in the infarct and immediate peri-infarct regions were excluded from counting. The sections were stained with DAPI to visualize nuclei and photographed with an Olympus BX41 microscope (Olympus America) equipped with a digital camera.
Measurement of fibrosis. Fixed hearts were embedded in paraffin, and mid-LV cross sections were stained with Trichrome-Masson. Images of LV area of each slide were prepared by Olympus BX41 Fig. 2 . Measurements of dipeptidyl peptidase IV (DPP-IV) activity and stroma-derived factor-1␣ (SDF-1␣) level. A: bar graph showed the activity of DPP-IV in heart from various experimental groups 7 days after myocardial infarction (MI) or 28 days after cell sheet implantation. *P Յ 0.05 was considered statistically significant; n ϭ 6 for each group. All values are expressed as means Ϯ SE. B: mass spectrometry demonstrated that fulllength recombinant SDF-1␣ is cleaved in heart lysates from vehicle (VEH)-or diprotin A (DIP)-treated rats 7 days after MI. Panel 1: a spectrum of mass calibrant, apomyoglobin. Panels 2 and 3: the spectra for the sample from VEH-or DIP-treated rat, respectively, after MI.
with a charge-coupled device camera (MagnaFire; Olympus). Fibrotic area and total LV area of each image were measured using the Image-Pro Plus (Media Cybernetics, Carlsbad, CA), and the percentage of the fibrosis was calculated as (fibrotic area/total LV area) ϫ 100.
Cardiac function assessment by echocardiograph. Echocardiography (iE33 Ultrasound System; Phillips) with a 15-MHz probe was performed on days 1, 7, 14, 21, and 28 after cell sheet placement to assess systolic and diastolic dimensions in addition to anterior wall thickness. Hearts were imaged in two-dimensional long-axis view at the level of the greatest LV diameter with animals under light general anesthesia. This view was used to position the M-mode cursor perpendicular to the LV anterior and posterior walls. LV end-diastolic and end-systolic dimensions were measured from M-mode recordings using the leading-edge method. LV ejection fraction (EF) was calculated as: EF (%)
Statistical analysis. Results were statistically analyzed with the use of the StatView 5.0 software package (Abacus Concepts, Berkeley, CA). All values were expressed as means Ϯ SE. Comparison between groups for echocardiographic longitudinal data was performed by two-way analysis of variance (ANOVA) for repeated measurements. All resulting differences were analyzed by one-Way ANOVA, followed by a Bonferroni/Dunn test or unpaired t-test. A P value Յ0.05 was considered statistically significant.
RESULTS
Characteristics of cell sheet. After 7 days of MSC culture for overconfluence (Fig. 1A) , temperature was decreased in the culture dish to 20°C for 10 min, causing the polymer substrate to become hydrophilic, resulting in confluent MSC sheet release (Fig. 1, B and D) . The thickness of monolayers after cell sheet detachment (Fig. 1D ) was ϳ2.5-fold greater than the cell thickness before cell sheet release (Fig. 1C) . Immunostaining revealed the presence of connexin-43, a major constituent of the gap junction (Fig. 1E) .
Diprotin A reduces cardiac DPP-IV activity and maintains posttranslational stabilization of SDF-1␣ activity in heart tissues. Depletion of CD26 (DPP-IV) by administration of diprotin A was first examined in myocardium 7 days after LAD occlusion or 28 days after cell sheet implantation. Myocardial Fig. 2A were undetectable in the MI ϩ DIP group, whereas DPP-IV was detected in the MI and MI ϩ VEH groups (P Ͻ 0.05). However, no significant difference was found between each group on day 28 after cell graft. Because it is difficult to differentiate between the cleaved and intact active forms of SDF-1␣ using Western blot or ELISA (26), we performed mass spectrometry in experiments where recombinant SDF-1␣ was incubated with lysates from heart tissue with the vehicle as a control or with diprotin A. We show results of SDF-1␣ by mass spectrometry on day 7 after LAD ligation. SDF-1␣ was not detected on day 28 after cell sheet graft in any of the groups (data not shown). Figure 2B , panel 1, shows a spectrum of mass calibrated with apomyoglobin. Figure 2B, panel 3 , shows a tissue sample extract from the diprotin A-treated group demonstrating a molecular target at 7970 Da, characteristic of SDF-1␣ protein, compared with a very small amplitude target for the unmodified SDF-1␣ (Fig.  2B, panel 2 ) from a vehicle-treated LV tissue sample.
DPP-IV activities illustrated in
Immunohistochemical analysis. Quantitative analysis of endothelial cells marked by vWF (Fig. 3, A-F) identified a significant increase in the number of small blood vessels in the cell graft area in the MSC CXCR4 ϩ VEH group (Fig. 3B ) compared with the MSC Null ϩ VEH group (Fig. 3A) . The number of small blood vessels was further increased in the MSC CXCR4 ϩ DIP group (Fig.  3C) . However, this increase in vascularity was completely inhibited in the MSC siRNA ϩ DIP group (Fig. 3G) . We interpret these results as a positive implication of CXCR4 expression as a participant in angiogenesis (data not shown for the MSC Null ϩ DIP or MSC siRNA ϩ DIP groups, which had similar vascularity to the MSC Null ϩ VEH group). The results also reveal that microvessels in the cell patch contained red blood cells (red arrows) in Fig. 3 , B and C, confirmation that these new vessels were functionally integrated with the native coronary vasculature. Similar results were also obtained for small vessel density in the peri-infarct border zone. Vascularity was increased significantly in the MSC CXCR4 ϩ VEH group (Fig. 3 , E and H) compared with the MSC Null ϩ VEH group and was increased further in the MSC CXCR4 ϩ DIP group (Fig. 3, F and H) . The vessel density was the highest in the MSC CXCR4 ϩ DIP group (Fig. 3H ). This increased vascularity was accompanied 28 days after cell sheet implantation by an increase in Y chromosome-positive nuclei (Y CHϩ ) in the peri-infarct border zone (Fig. 4, A-D) . Y CHϩ were increased significantly in the MSC CXCR4 ϩ VEH group (Fig. 4B ) compared with the MSC Null ϩ VEH group (Fig. 4A ) and increased further in the MSC CXCR4 ϩ DIP group (Fig. 4C) . The number of Y CHϩ increase was completely abrogated in MSC siRNA ϩ DIP group, suggesting that CXCR4 expression plays a significant role in cell penetration from the cell patch to the ischemic myocardial area (data not shown for the other groups, which were similar to the MSC Null ϩ VEH group; Fig. 4D ). Figure 4 illustrates the antiapoptotic effect of diprotin A 4 days after LAD ligation. A significant reduction in the number of TUNEL-positive nuclei was observed in the diprotin Atreated group compared with that in the MI group (Fig. 4,  E-H) . There was no significant difference observed in the number of TUNEL-positive nuclei between the MI and MI ϩ VEH groups. Figure 5 indicates the heart sections for Masson-Trichome staining (A) and percentage of fibrosis (B). On day 28 after cell graft, the percentage of fibrosis in the LV wall in the MSC Null ϩ VEH, MSC CXCR4 ϩ VEH, MSC Null ϩ DIP, MSC CXCR4 ϩ DIP, and MSC siRNA ϩ DIP groups was reduced significantly compared with the MI group and was reduced further in the MSC CXCR4 ϩ VEH, MSC Null ϩ DIP, and MSC CXCR4 ϩ DIP groups compared with the MSC Null ϩ VEH group. However, this is not the case with MSC siRNA ϩ DIP group, which was similar to the MSC Null ϩ VEH group (Fig. 5, A and B) . The percentage of fibrosis was the lowest in the MSC CXCR4 ϩ DIP group compared with any other groups (Fig. 5, A and B) .
Parameters for cardiac function. Twenty-eight days after cell sheet implantation, LV function, analyzed by two-dimensional echocardiography, showed a significant improvement in left ventricular end-diastolic and end-systolic dimensions in all rats that received cell sheet implantation, except for rats that received MSC siRNA ϩ DIP (P Ͻ 0.05; Fig. 6, A-E) , where LV functional indices were similar to those in the MI-only group. There was no difference in LV functional indices between the MSC Null ϩ VEH and MSC Null ϩ DIP groups. LV function was improved further in the group of MSC CXCR4 ϩ DIP compared with that measured in any other group (imaging not shown for other groups, which were similar to MSC Null ϩ VEH group). Consistent with LV end-diastolic and -systolic dimension restoration, LV EF and FS were higher in all of the groups that received cell sheets compared with the MI group. EF and FS in the MSC CXCR4 ϩ VEH group were significantly higher than in the MI, MSC Null ϩ VEH, or MSC Null ϩ DIP groups. These LV global function indicators were not different in the MSC Null ϩ VEH or MSC Null ϩ DIP groups. EF and FS values were significantly higher in the MSC CXCR4 ϩ DIP group than in any other group (Fig. 6, F and G) . Impaired cardiac contractility in the anterior wall resulted in akinetic regions with paradoxical motion in systole, indicative of paradoxical systolic aneurismal bulging in the MSC CXCR4 ϩ VEH group (Fig. 6H3) . In contrast, there was a coordinated concentric contraction recorded from the mid-LV region of the MI in the diprotin A-treated (MSC CXCR4 ϩ DIP) group that was clearly visualized in both long-axis (Fig. 6, H2 and H4 ) and short-axis echocardiographic imaging (Fig. 6H6) . Quantitatively, these data clearly demonstrate that anterior wall thickness and its behavior during the entire cardiac cycle in the MSC CXCR4 ϩ DIP group were improved more significantly than that recorded in the MSC CXCR4 ϩ VEH group (Fig. 6H7) . 
DISCUSSION
Cell-based therapy appears to be a promising modality for myocardial repair and reverse remodeling in ischemic heart disease (10) . Direct injection of isolated cardiomyocytes into injured hearts has thus far failed to improve cardiac function since these cells do not thrive or integrate within the recipient heart (29) . Cell sheet grafts with genetically engineered properties to prolong cell survival and promote and coordinate integration of new muscle and blood vessel networks integrated with native coronary circulation offer a potentially attractive approach to repair and replace dead or damaged myocardium after obstructive coronary artery disease, leading to MI. The results of the present study illustrate several advantages of this cell sheet approach. First, sustaining a high level of SDF-1␣ as a homing signal arising from regions of myocardial ischemic injury by diprotin A treatment increased the number of MSC CXCR4 penetrating from the cell graft to the ischemic myocardium. Second, we present evidence that the monolayered MSC implantation, when performed as a combination of pharmacological inhibition of DPP-IV activity by diprotin A and genetic manipulation of MSC CXCR4 when applied to the epicardial surface of ischemic tissue of the LV following MI, will promote angiogenesis integrated to the native coronary circulation (Fig. 3) . Third, the self-proliferation of MSC in situ leads to formation of a thick stratum that appears to reverse cardiac remodeling and its pump function after MI.
The results of this study further support the role of SDF-1␣ as a major chemokine in initiating progenitor/stem cell migration and homing to the site of ischemia (21) . This role for SDF-1␣ has been explored in a myriad of models using several different methods. Several studies have targeted enhancement of myocardial SDF-1␣ levels by pharmacological or genetically manipulated means (33) . Generally speaking, SDF-1␣ is upregulated in the heart immediately after LAD occlusion and maintains this level for short periods (26) . Similarly hypoxic preconditioning stimulates SDF-1␣/CXCR4 interaction, allowing migration and differentiation of cardiac stem cells in the infarcted myocardium (32) . The release of SDF-1␣ from the ischemic area serves as a strong chemoattractant for CXCR4 ϩ progenitor cells, which protect the ischemic area by paracrine factors (28) or by regeneration (29) . Although we did not directly measure paracrine factors associated with SDF-1␣ in heart tissue after administered diprotin A, it is reported that SDF-1␣ is involved in autocrine/paracrine regulation of progenitor cell development and survival (9) . Blocking SDF-1␣ in apolipoprotein E (apoE)-deficient (apoE Ϫ/Ϫ ) mice after vascular intimal injury resulted in a significant reduction of the neointimal area by inhibiting the accumulation of bone marrow-derived smooth muscle cell (SMC) progenitors in the neointima (31) . The effect of SDF-1␣ on SMC progenitor recruitment is dependent on the expression of CXCR4 in bone marrow cells because neointimal hyperplasia and SMC content are diminished in apoE Ϫ/Ϫ mice after bone marrow reconstitution with fetal hematopoietic stem cells from CXCR4 Ϫ/Ϫ mice (31). Consistent with this view, blockade of CXCR4 by either monoclonal antibody or AMD3100 partially inhibited blood flow recovery of ischemic hearts or vascular endothelial growth factor (VEGF)-mediated incremental revascularization (18) . More recent studies show that diprotin A, the inhibitor of CD26/DDP-IV, stabilizes active myocardial SDF-1␣, which enhances stem/progenitor cell mobilization to the ischemic myocardium (30) . Therefore, we intended to establish a noninvasive pharmacological strategy for SDF-1␣ stabilization in ischemic hearts to enhance CXCR4 ϩ -overexpressing MSC from cell sheet to increase penetration and enhance angiogenesis into an infarcted area, with the goal of restoring heart function after MI.
Our results show that diprotin A treatment appears to have an incremental effect only when combined with transplanted MSC CXCR4 cells. This is because the expression of CXCR4 is for efficient SDF-1␣-induced progenitor/stem cell mobilization. SDF-1␣/CXCR4 interactions are important for the recruitment of CXCR4-positive progenitor cells to the heart after MI, which further increases their homing to the site of injury. Increased CXCR4 expression through adenoviral vectors enhances vascularization in the damaged myocardium, and thus SDF-1␣/CXCR4 axis seems to be particularly important in progenitor cell chemotaxis, homing, and survival in the damaged myocardium (32) . CXCR4 expression is regulated by various factors, including cytokines, chemokines, stromal cells, adhesion molecules, and proteolytic enzymes (15) . We genetically engineered male rat MSC using adenoviral transduction to overexpress CXCR4/EGFP, which improved cell migration, released angiogenic factors, and restored heart function after MI (6) . Our results demonstrate a large number of newly formed blood vessels in both the cell patch and the underlying infarcted area of the MSC CXCR4 ϩ DIP group, which suggests that a supply of nutrients and oxygen from the native circulation is available. SDF-1␣-CXCR4 interactions are also involved in other stem cell functions (16, 18) . CXCR4 expression is positively regulated by transcription factors related to stress/hypoxia and tissue damage, such as NF-B (3), hypoxiainducible factor-1␣ (23), glucocorticoids (11) , lysophosphatidylcholine (1), transforming growth factor (TGF)␤1 (28), VEGF (18), interferon-␣ (8), and several interleukins (IL-2, IL-4, and IL-7) (22) . Thus, it is likely that any stress-related condition to which the heart is exposed may result in upregulation of CXCR4 expression on stem cells. SDF-1␣ induced phosphorylation of MAPK p42/44 and serine-threonine kinase Akt, and upregulated VEGF after coronary occlusion has been documented in vivo (18) . Akt is widely accepted as being associated with cell survival/proliferation. In addition, apoptosis is the consequence of genetically programmed cell death that can be initiated by a number of stimuli, such as growth factor withdrawal, signaling through apoptotic receptors, or cell-damaging stress (17) . One of the mechanisms through which diprotin A contributes to reverse heart remodeling following MI could be through its antiapoptotic role, which is consistent with previous reports that SDF-1␣ possesses antiapoptotic activity (4). Our observation that diprotin A elicits such a response within 4 days of its administration suggests that inhibition of apoptosis could be one possible mechanism. High levels of SDF-1␣ induce the attraction and accumulation of transplanted endothelial progenitor cells at sites of ischemia and enhance neovascularization after endothelial progenitor cell transplantation (26) .
CONCLUSION
Implantation of a cell sheet with combination of genetically manipulated progenitor cells over scarred areas of myocardium with systemically preadministered diprotin A subsequent to MI results in antiapoptosis, enhanced and temporally coordinated angiogenesis connected to native coronary circulation, and improved regional and global left ventricular function.
